Tekla Capital Management LLC G1 Therapeutics, Inc. Call Options Transaction History
Tekla Capital Management LLC
- $2.53 Billion
- Q2 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GTHX
# of Institutions
95Shares Held
14.7MCall Options Held
631KPut Options Held
347K-
Vanguard Group Inc Valley Forge, PA2.08MShares$5.14 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA951KShares$2.35 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny904KShares$2.23 Million0.01% of portfolio
-
Raymond James & Associates St Petersburg, FL803KShares$1.98 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY785KShares$1.94 Million0.0% of portfolio
About G1 Therapeutics, Inc.
- Ticker GTHX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,746,800
- Market Cap $106M
- Description
- G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...